DHK Financial Advisors Inc. increased its stake in Lam Research Co. (NASDAQ:LRCX – Free Report) by 900.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,850 shares of the semiconductor company’s stock after acquiring an additional 2,565 shares during the quarter. DHK Financial Advisors Inc.’s holdings in Lam Research were worth $207,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of LRCX. Sunbelt Securities Inc. lifted its stake in Lam Research by 3.9% during the second quarter. Sunbelt Securities Inc. now owns 1,533 shares of the semiconductor company’s stock valued at $1,633,000 after buying an additional 58 shares in the last quarter. Quarry LP boosted its stake in Lam Research by 175.0% in the 2nd quarter. Quarry LP now owns 88 shares of the semiconductor company’s stock worth $94,000 after purchasing an additional 56 shares during the period. Advisory Alpha LLC acquired a new stake in Lam Research during the 2nd quarter valued at $256,000. 3Chopt Investment Partners LLC purchased a new stake in shares of Lam Research in the second quarter valued at $1,105,000. Finally, Cetera Investment Advisers grew its holdings in shares of Lam Research by 2.1% during the second quarter. Cetera Investment Advisers now owns 28,382 shares of the semiconductor company’s stock valued at $30,224,000 after buying an additional 585 shares in the last quarter. 84.61% of the stock is owned by institutional investors and hedge funds.
Lam Research Stock Down 1.5 %
Shares of NASDAQ LRCX opened at $74.51 on Wednesday. Lam Research Co. has a 12-month low of $68.87 and a 12-month high of $113.00. The firm’s 50-day simple moving average is $75.53 and its 200 day simple moving average is $79.37. The company has a quick ratio of 1.74, a current ratio of 2.53 and a debt-to-equity ratio of 0.53. The company has a market cap of $95.87 billion, a price-to-earnings ratio of 24.08, a price-to-earnings-growth ratio of 1.53 and a beta of 1.45.
Lam Research Dividend Announcement
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on LRCX shares. Cantor Fitzgerald restated a “neutral” rating and set a $100.00 price objective on shares of Lam Research in a research report on Thursday, October 24th. KeyCorp raised shares of Lam Research from a “sector weight” rating to an “overweight” rating and set a $95.00 target price for the company in a research note on Friday, January 17th. Barclays cut their price objective on Lam Research from $90.00 to $75.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Wolfe Research lowered Lam Research from an “outperform” rating to a “peer perform” rating in a research report on Wednesday, January 15th. Finally, Wells Fargo & Company reduced their price target on Lam Research from $83.00 to $82.00 and set an “equal weight” rating for the company in a report on Monday, January 13th. Nine equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Lam Research currently has an average rating of “Moderate Buy” and a consensus target price of $95.77.
Get Our Latest Report on Lam Research
Lam Research Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Further Reading
- Five stocks we like better than Lam Research
- Which Wall Street Analysts are the Most Accurate?
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is a SEC Filing?
- What Does the Future Hold for Eli Lilly?
- Why Are These Companies Considered Blue Chips?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.